首页> 中文学位 >CXCR1/2拮抗剂G31P在改善溃疡性结肠炎作用的研究
【6h】

CXCR1/2拮抗剂G31P在改善溃疡性结肠炎作用的研究

代理获取

目录

声明

TABLE OF CONTENTS

摘要

ABSTRACT

INTRODUCTION

1.0 Background

1.1 Definition of inflammatory bowel disease

1.2 The role of cytokines in IBD

1.3 The role of anti-immune cells trafficking in IBD

1.4 Challenges in IBD

1.5 Epidemiology of IBD

1.6 The role of CXCL8 (IL8) in inflammation

1.7 The structure and function of hG31P as anti-inflammatory and anti-cancer

1.8 The role of the gut mierobiome in IBD

1.9 Genetics and IBD

1.10 Problem statement of this study

1.11 Research questions

1.12 Objectives of this study

1.13 Specific objectives of this study

MATERIALS AND METHODS

2.0 Materials

2.1 Methods

2.1.0 Ethical consideration

2.1.1 Cell culture

2.1.3 ELISA assay

2.1.6 RNA extraction and cDNA amplification

2.1.7 Protein extraction and western blotting

2.1.8 Experimental subjects

2.1.9 Preparation of Lactobacillus acidophilus

2.1.10 Induction of colitis and treatment

2.1.11 Histological staining

2.1.12 Immunohistochemistry

2.1.13 Statistical analysis

RESULTS

3.1 G31P restricts THP-1 monocytes proliferation and CXCL8-CXCR1/2 expressions

3.2 G31P treatments down-regulate inflammatory cytokines expression in LPS induced inflammation of THP-1 monocytes

3.3 G31P treatment down-regulates mRNA expression of inflammatory associated enzymes and restricts monocyte-derived macrophage migration in LPS induced THP-1 cells

3.4 G31P regulates inflammatory associated transcription factors

3.5 G31P regulates inflammatory cytokines expression via AKT1,ERK1/2,and ROS pathways

3.6 G31P and G31P+LACT treatments protect against DSS induced UC

3.7 G31P and G31P+LACT treatments differentially inhibit inflammatory cytokines in DSS induced UC

3.8 G31P and G31P+LACT treatments restrict immune cells trafficking to in flamed colonin DSS induced UC

3.9 G31P and G31P+LACT treatments improved colonic fibrosis,and enhanced tight junction proteins expression in DSS induced colitis

3.10 G31P and G31P+LACT treatments modulate Egr1 and HI-1α expressions via ERK and AKTpathways respectively

DISCUSSION AND CONCLUSION

4.0 Discussion

4.0.0 In vitro

4.0.1 In vivo

4.1 Conclusion

REFERENCES

LITERATURE REVIEW

APPENDIX

ACKNOWLEDGEMENT

LIST OF PUBLICATIONS

展开▼

著录项

  • 作者

    WILLIAMS WALANA;

  • 作者单位

    大连医科大学;

  • 授予单位 大连医科大学;
  • 学科 IMMUNOLOGY
  • 授予学位 博士
  • 导师姓名 LI FANG;
  • 年度 2019
  • 页码
  • 总页数
  • 原文格式 PDF
  • 正文语种 中文
  • 中图分类
  • 关键词

    CXCR1; 拮抗剂; 溃疡性结肠炎;

相似文献

  • 中文文献
  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号